Predicate |
Object |
contentType |
Journal Article |
endingPage |
2360 |
issn |
1948-5875 |
issueIdentifier |
12 |
pageRange |
2359-2360 |
publicationName |
ACS Medicinal Chemistry Letters |
startingPage |
2359 |
bibliographicCitation |
Kargbo RB. Breakthrough in Degradation of BCR-ABL Fusion Protein for the Treatment of Cancer. ACS Med. Chem. Lett. 2020 Nov 20;11(12):2359–60. doi: 10.1021/acsmedchemlett.0c00587. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5539-6343 |
date |
2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/33335652 https://doi.org/10.1021/acsmedchemlett.0c00587 https://pubmed.ncbi.nlm.nih.gov/PMC7734636 |
isPartOf |
https://portal.issn.org/resource/ISSN/1948-5875 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Breakthrough in Degradation of BCR-ABL Fusion Protein for the Treatment of Cancer |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 |